Patent assignee · US · COMPANY

Theraclone Sciences Inc.

28Patents
28Active
28Granted
50Portfolio score

Filing activity: Nov 12, 2008 → Jun 5, 2024 · 7 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9051362B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 14 Active
US9464131B2 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Chemistry; Metallurgy 14 Active
US10087239B2 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Chemistry; Metallurgy 12 Active
US8916160B2 Compositions and methods for the therapy and diagnosis of influenza Physics 8 Active
US8057796B2 Compositions and methods for the therapy and diagnosis of influenza Chemistry; Metallurgy 6 Active
US8114402B2 Compositions and methods for the therapy and diagnosis of influenza Chemistry; Metallurgy 4 Active
US8329188B2 Human M2e peptide immunogens Emerging Cross-Sectional Technologies 2 Active
US8460671B2 Compositions and methods for the therapy and diagnosis of influenza Chemistry; Metallurgy 2 Active
US8900590B2 Anti-hemagglutinin antibody compositions and methods of use thereof Physics 2 Active
US8268309B2 Compositions and methods for the therapy and diagnosis of cytomegalovirus Physics 2 Active
US11319362B2 Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies Chemistry; Metallurgy 2 Active
US7982012B2 Compositions and methods for the therapy and diagnosis of cytomegalovirus Physics 1 Active
US8974788B2 Compositions and methods for the therapy and diagnosis of influenza Physics 1 Active
US8609101B2 Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies Emerging Cross-Sectional Technologies 1 Active
US8858948B2 Compositions and methods for the therapy and diagnosis of influenza Chemistry; Metallurgy 1 Active
US8852594B2 Compositions and methods for the therapy and diagnosis of cytomegalovirus infections Physics 1 Active
US8822651B2 Human rhinovirus (HRV) antibodies Chemistry; Metallurgy 0 Active
US10865234B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US12312396B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US11584789B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US11845789B2 Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies Chemistry; Metallurgy 0 Active
US9920111B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US8932597B2 Human M2e peptide immunogens Emerging Cross-Sectional Technologies 0 Active
US12018067B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active
US10407493B2 Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.